Eyeworld CME Supplements

EW MAR 2018 - Supported by unrestricted educational grants from Shire, TearLab, and TearScience

This is a supplement to EyeWorld Magazine that doctors can take a test after reading and receive CME credits for.

Issue link: http://cmesupplements.eyeworld.org/i/944604

Contents of this Issue

Navigation

Page 7 of 7

8 1. Although symptoms may not correlate well with the clinical signs of dry eye disease, which of the following is one of the most important symptoms of dry eye disease? a. Fluctuation in vision b. Dryness c. Foreign body sensation d. Blurry vision 2. Given that the tear film is a critical refractive system in the eye, what percentage of the optical power comes from the cornea? a. 25% (1/4) b. 33% (1/3) c. 66% (2/3) d. 20% (1/5) 3. According to the new DEWS II report, what is the ultimate goal in the management of dry eye disease? a. Select a single primary treatment b. Restore homeostasis c. Normalize osmolarity d. Identify the type of dry eye disease (i.e., aqueous deficient dry eye, evaporative dry eye, or hybrid) 4. A 50-year-old woman presents with complaints of chronic foreign body sensation, redness, and ocular fatigue. She says she can't see throughout the day and her eyes feel tired. She has a history of LASIK for myopia and a PRK enhancement. She has no history of autoimmune diseases. Her TBUT readings are 4–5 sec, MMP-9 is weakly positive, and her osmolarity is elevated. She supplements with artificial tears and omega-3s. She has been on cyclosporine for 2 years, has added lifitegrast ophthalmic solution 5% within the past 6 months, and reports improvement. However, she is still symptomatic. What would you do next? a. Examine meibomian glands with a cotton swab at the slit lamp. If any amount of oil flows when glands are expressed, rule out meibomian gland dysfunction. b. Examine meibomian glands with a cotton swab at the slit lamp. If any amount of oil flows when glands are expressed, continue with further meibography diagnostics. Not all atrophy can be seen at the slit lamp. c. Redo TBUT, MMP-9, and osmolarity diagnostics d. Continue treatment as is CME questions (circle the correct answer) To claim credit, please fax the test and fully completed form by July 31, 2018 to 703-547-8842, email to KSabol@ascrs.org, or mail to: EyeWorld, 4000 Legato Road, Suite 700, Fairfax, VA 22033, Attn: March 2018 CME Supplement ASCRS Member ID (optional): First/Last Name/Degree: Practice: Address: City, State, Zip, Country: Phone: Email: Please print email address legibly, as CME certificate will be emailed to the address provided. Copyright 2018 ASCRS Ophthalmic Corporation. All rights reserved. The views expressed here do not necessarily reflect those of the editor, editorial board, or the publisher, and in no way imply endorsement by EyeWorld or ASCRS. To take this test online and claim credit, go to bit.ly/2E60E7R, or complete the test below and fax, mail, or email it in. Customizing modern OSD therapies to individual patient needs

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld CME Supplements - EW MAR 2018 - Supported by unrestricted educational grants from Shire, TearLab, and TearScience